☆ 4.7 Editorial Material

The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context

EUROPEAN HEART JOURNAL (2021)

Get Full Text
Add to Collection

Journal

EUROPEAN HEART JOURNAL
Volume 42, Issue 13, Pages 1199-1202

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehz916

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Funding

  1. AstraZeneca

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.